Patent: 7,279,159
✉ Email this page to a colleague
Summary for Patent: 7,279,159
| Title: | VEGF inhibitor polypeptides |
| Abstract: | Nucleic acid molecules and multimeric proteins capable of binding vascular endothelial growth factor (VEGF). VEGF traps are disclosed which are therapeutically useful for treating VEGF-associated conditions and diseases, and are specifically designed for local administration to specific organs, tissues, and/or cells. |
| Inventor(s): | Thomas J. Daly, James P. Fandl, Nicholas J. Papadopoulos |
| Assignee: | Regeneron Pharmaceuticals Inc |
| Application Number: | US10/880,021 |
| Patent Claims: | see list of patent claims |
| Patent landscape, scope, and claims summary: |
More… ↓ |
Details for Patent 7,279,159
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Sanofi-aventis U.s. Llc | ZALTRAP | ziv-aflibercept | Injection | 125418 | August 03, 2012 | ⤷ Start Trial | 2024-06-29 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
